← Leaderboards
Xian-Liang Tang
University Of Louisville
$2,255,729
Attributed
$4,060,441
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $749.7K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,060,441 · 3
By mechanism
R01$2,349,875 · 1
R44$1,485,754 · 1
R43$224,812 · 1
Top collaborators
- Gregg Rokosh4 shared
- Philip Bauer3 shared
- Claudio Maldonado3 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Daniel Joseph Conklin$13,454,433
- Roberto Bolli$36,238,342
- Aruni Bhatnagar Bhatnagar$35,834,843
- Gregg Rokosh$3,941,007
- Steven P. Jones$14,162,871
Others in their field
Top investigators on “Reperfusion Therapy”
- Peter Scott Heeger · Case Western Reserve University$36,944,600
- Myron D Ginsberg · University Of Miami School Of Medicine$18,278,885
- Joren C Madsen · Massachusetts General Hospital$17,973,973
- Ke Cheng · North Carolina State University Raleigh$17,619,678
- Junichi Sadoshima · Rutgers Biomedical And Health Sciences$17,157,280
- Joseph Paul Broderick · University Of Cincinnati$17,012,741
Research focus
Reperfusion TherapyMyocardial IschemiaMyocardial InfarctionBaseCellsMyocardiumFamily SuidaeMyocardialHeartInfarctionAtherosclerosisCholesterolHypercholesterolemiaCoronary OcclusionsDoseCell TypeSignal TransductionPlasmaInjuryIn VivoBlood VesselsCardiacAnimalsCell Physiology
Grant awards (11)
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$736,042
R44 · FY2019 · HL
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$749,712
R44 · FY2018 · HL
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$224,812
R43 · FY2016 · HL
Hypercholesterolemia in Cardiac Function, Survival and Repair$329,670
R01 · FY2012 · HL · contact PI
Hypercholesterolemia in Cardiac Function, Survival and Repair$333,000
R01 · FY2011 · HL · contact PI
Hypercholesterolemia in Cardiac Function, Survival and Repair$333,000
R01 · FY2010 · HL · contact PI
Hypercholesterolemia in Cardiac Function, Survival and Repair$333,000
R01 · FY2009 · HL · contact PI
Late Preconditioning in Hypercholesterolemia$251,205
R01 · FY2006 · HL · contact PI
Late Preconditioning in Hypercholesterolemia$257,250
R01 · FY2005 · HL
Late Preconditioning in Hypercholesterolemia$257,250
R01 · FY2004 · HL
Late Preconditioning in Hypercholesterolemia$255,500
R01 · FY2003 · HL